Background {#Sec1}
==========

Conventional laboratory methods like enzyme-linked immunosorbent assay, nucleic acid hybridization technique, and polymerase chain reaction (PCR) are all common and inexpensive diagnostic and research tools utilized in virology \[[@CR1]\]. However, as these assays are highly dependent on reagents (primers, probes, antibodies) developed from previously known and characterized viruses, they might be ineffective for the identification of new viral variants, new pathogens or a mixed population of pathogens that have high genetic divergence from those described previously \[[@CR1], [@CR2]\]. Next-generation sequencing (NGS) technologies enable large numbers of samples to undergo parallel sequencing, and can be used for the detection and characterization of multiple agents from one sample. The use of sequence-independent amplification of viral nucleic acids eliminates the need for prior knowledge of genomic sequences and provides advantages over traditional methods such as PCR amplification or microarray hybridization dependent on target-specific primers \[[@CR2], [@CR3]\]. NGS technologies allow screening of clinical and environmental samples for the presence of viral pathogens, including previously unknown viruses \[[@CR4]\]. This has led to the discovery of numerous viral pathogens \[[@CR4]--[@CR6]\], including 2009 pandemic influenza A, a novel pegivirus, Canine bocavirus 3, and a novel hepacivirus \[[@CR7]--[@CR10]\].

The majority of previously employed techniques used virus enrichment prior to cDNA synthesis and library preparation, or used specific primers for amplification. Virion enrichment steps such as centrifugation, polyethylene glycol precipitation, ultrafiltration, chloroform treatment or nuclease treatment have been used for RNA viruses \[[@CR3], [@CR11], [@CR12]\]. Other techniques, such as gDNA depletion and host RNA depletion to enrich for viral RNA \[[@CR13]\] and DNase pretreatment of the allantoic fluid to enrich for viral particles, have also been described \[[@CR14]\]. Different methods have been employed for producing cDNA following enrichment, including sequence-independent single primer amplification (SISPA) and universal primers which have been used for sequencing RNA viruses \[[@CR4], [@CR15]\] including Newcastle disease virus (NDV) \[[@CR11]\] and avian paramyxovirus (APMV) 4 and 6 \[[@CR16]\].

The genus *Avulavirus* of the family *Paramyxoviridae,* order *Mononegavirales*, consists of 14 known avian paramyxovirus serotypes (APMV 1 -- 14) \[[@CR17]--[@CR19]\]. Of these, APMV-1, synonymous with Newcastle disease virus, is the most widely characterized and studied due to the economic importance of Newcastle disease (ND) caused by virulent strains of the virus. Newcastle disease is one of the most significant poultry diseases and infects both wild and domestic avian hosts. NDV has a single-stranded, non-segmented, negative-sense RNA genome consisting of six genes in order of 3' to 5': nucleocapsid (NP), phosphoprotein (P), matrix (M), fusion (F), hemagglutinin-neuraminidase (HN), and polymerase (L), coding for these six structural proteins and at least one additional V protein \[[@CR20]--[@CR22]\]. Newcastle disease viruses have three genome sizes -- 15186, 15192 and 15198 nucleotides, and are genetically grouped into two divergent classes that are further classified in genotypes \[[@CR23]--[@CR25]\].

Newcastle disease viruses are constantly evolving and different genetic groups undergo simultaneous evolutionary changes in different geographical locations \[[@CR22], [@CR26]\] making the available genetic makeup information outdated. These evolutionary changes present challenges for prompt diagnosis. Some currently validated methods are target-oriented and might fail to detect new viral genetic variants \[[@CR27]--[@CR29]\]. Lack of complete genetic information for many NDV isolates further hampers the better understanding of Newcastle disease evolution and epidemiology. Furthermore, mixed viral infection are not uncommon in animals, and in the case of poultry, they are quite frequent \[[@CR30]\]. Efficient and accurate identification of these pathogens is essential for the development of adequate disease control strategies. These challenges require an approach that provides *de novo*, rapid and high-quality genetic characterization of full-length viral genomes.

Until recently, genome sequencing of small RNA viruses, including NDV, has been performed using overlapping genome amplification with primer pairs. This approach is laborious, depends on preexisting information, and produces very low depth. NGS advances provide tools for deep sequencing of multiple viral strains in a short time. However, the simultaneous cost- and time-effective sequencing and characterization of a large number of NDV genomes has not yet been reported. The aim of the current study was to utilize sequence-independent NGS technologies applied to viral nucleic acids for the simultaneous and rapid characterization of multiple NDV genomes. We demonstrate a straightforward, efficient protocol for multiplexed sequencing using a single flow cell on the Illumina MiSeq platform coupled with a detailed customized Galaxy workflow for *de novo* assembly that allows for quick and accurate generation of near-full-length, or full-length, genome sequences of dozens of isolates, simultaneously. Furthermore, we report the efficient detection and complete sequencing of contaminant RNA viruses.

Methods {#Sec2}
=======

Virus propagation {#Sec3}
-----------------

Twenty nine NDV and one APMV-13 isolates were submitted to the Southeast Poultry Research Laboratory of the USDA in Athens, Georgia, USA. The viruses were isolated in Pakistan (*n* = 15), Nigeria (*n* = 9) and Ukraine (*n* = 6) between 2003 and 2015. Viruses were propagated in 9-to-11-day-old specific-pathogen-free (SPF) embryonating chicken eggs \[[@CR31]\]. The background information of the 30 isolates used in the study is summarized in Additional file [1](#MOESM1){ref-type="media"}: Table S1.

RNA isolation {#Sec4}
-------------

RNA from each sample was extracted from allantoic fluids. Two milliliters (equal volumes of 0.25 ml) of each sample were aliquoted into 8 microtubes, each containing 0.75 ml of TRIZOL LS (Invitrogen, USA). After 5 min of incubation, 0.2 ml of chloroform was added to each tube and shaken vigorously. After 10 min of additional incubation at room temperature, tubes were centrifuged at 12000 × g for 15 min at 4 °C. The aqueous phase from all eight tubes was removed and pooled for each sample. Two milliliters of aqueous layer of each sample were treated with 4 μl Turbo DNase 2U/μl (Ambion, USA) for 15 min at 37 °C and then placed on ice. The extraction proceeded using the QIAamp® Viral RNA Mini Kit (Qiagen, USA) according to the manufacturer's instructions. Briefly, DNase-treated aqueous phase was passed through a spin column for RNA absorption on the QIAamp silica membrane followed by washing with 2 ml of provided buffers AW1 and AW2 using the QIAvac 24 Plus vacuum manifold (Qiagen, USA). The RNA was eluted in 50 μl buffer AVE. Eluted RNA was quantified using a Qubit® RNA HS Assay Kit in a Qubit® fluorometer (ThermoFisher Scientific, USA) and stored at -20 °C until further use.

NDV RNA capture {#Sec5}
---------------

A set of three biotinylated oligonucleotides designed from consensus of alignment of 330 available NDV genomes were used for NDV RNA capture (Oligo 1 -- 5'- AGA GAA TCT GTG AGG TAC GA/3Bio -3' at nucleotide position 8; Oligo 2 -- 5' -TTC TCA AGT CAT CGT GAC AG/3Bio -3' at position 5905; Oligo 3 -- 5' - CCC TGC ATC TCT CTA CAG/3Bio -3' at position 12226) (GenBank accession number AF431744). RNA capture reactions were performed using 50 μl RNA incubated with 167 μl 6X saline-sodium phosphate-EDTA buffer (900 mM NaCl, 60 mM NaH~2~PO~4~, 60 mM Na~2~EDTA), 2 μl RNaseOUT 40 U/μl (Invitrogen, USA) and 1.5 μl 100 μM mix of the three primers. Reactions were performed at 70 °C for 5 min, followed by 15 min at 55 °C. Two hundred fifty microliters of 1X binding and wash buffer solution (2 M NaCl) containing 12.5 μl (0.05%) Sera-Mag beads (magnetic streptavidin-coated beads, GE Healthcare Life Sciences, USA) was prepared for each sample and mixed with the capture reaction products for binding. Washing was done on a magnetic stand with 500 μl of 0.5X binding and wash buffer one time and twice with bead wash buffer (5 M NaCl, 1 M Tris-HCl \[pH 7.5\], 0.5 M EDTA, and 0.01% Tween® 20) to remove unbound RNA. Viral RNA was recovered by adding 19 μl of 10 mM Tris-HCl (pH 7.5) to the bead mixture and incubating at 65 °C for 5 min followed by cooling on ice until the next step. In a separate experiment, a comparison with three known NDV was performed and the libraries were prepared side-by-side with and without the capture step, while all remaining steps of the library preparation were identical.

Reverse transcription {#Sec6}
---------------------

Reverse transcription reactions were performed using the M-MLV Reverse Transcriptase (Moloney Murine Leukemia Virus Reverse Transcriptase, Invitrogen, USA) and 10 μl RNA (concentration varied from below 250 pg/μl to 55 ng/μl), 1.0 μl Random Primers mix (3 μg/μl) (Invitrogen, USA) and following manufacturer's instruction. The cDNA products were purified using 60 μl Agencourt® RNAClean® XP beads (Beckman Coulter, USA) as per manufacturer's instructions. Purified cDNA were recovered in 15 μl of 10 mM Tris-Cl (pH 7.5) and quantified using a Qubit® ssDNA Assay Kit (ThermoFisher Scientific, USA) on the Qubit® fluorometer.

Library preparation, quality and quantity assessment {#Sec7}
----------------------------------------------------

DNA libraries (*n* = 30, one library for each sample), were prepared for deep sequencing using 1 ng purified cDNA (0.2 ng/μl in molecular grade water) and the Nextera XT DNA Library Preparation Kit (Illumina, USA) following the manufacturer\'s protocol. The resulting dsDNA products were purified with 30 μl Agencourt® AMPure® XP beads (Beckman Coulter, USA) by incubating at room temperature for 5 min followed by two washes with 200 μl 80% ethanol on a magnetic stand. The tubes with the beads were air dried for 10 to 15 min at room temperature and the library products were recovered in 52.5 μl of Resuspension Buffer. The quality and fragment length distribution for each library was assessed using the Agilent High Sensitivity DNA Kit (Agilent Technologies, USA) on the Agilent 2100 Bioanalyzer (Agilent Technologies, Germany). The Qubit® fluorometer and the Qubit®dsDNA HS Assay Kit were used for measuring the concentration of the libraries.

Equimolar dilution and pooling of the NGS libraries {#Sec8}
---------------------------------------------------

All libraries for NGS were diluted to a 4 nM concentration, based on their determined concentrations and fragment sizes. Equal volumes of 5 μl of each library were pooled and denatured with NaOH (0.2 N final concentration) for 5 min. The pooled mixture was vortexed and spun briefly and incubated at room temperature for 5 min. The pool was further diluted to 20 pM concentration with chilled HT1 hybridization buffer (Illumina, USA). Using the same buffer, the final concentration of the library pool was diluted to 10 pM. Control library (3% PhiX library, Illumina, USA) was added and the pool was snap-chilled on ice. The library pool (600 μl) was loaded in the flow cell of the 500 cycle MiSeq Reagent Kit v2 (Illumina, USA) and pair-end sequencing (2 × 250 bp) was performed on the Illumina MiSeq instrument (Illumina, USA). After automated cluster generation in MiSeq, the sequencing reads were processed and all statistical data generated by the instrument were collected and summarized.

Genome assembly {#Sec9}
---------------

A workflow was designed to perform pre-processing and assembly of the raw sequencing data as diagrammed in Fig. [1](#Fig1){ref-type="fig"} using the Galaxy platform interface \[[@CR32]\]. Processing was carried out via Galaxy and PBS/Torque on a local dual node 128-core cluster. Briefly, raw read quality was assessed using FastQC \[[@CR33]\] and residual adapter sequences were trimmed using Cutadapt v1.6 \[[@CR34]\]. Trimmed reads were mapped against the *Gallus* and PhiX174 reference genomes using BWA-MEM v0.2.1 in order to identify host and control library read contamination \[[@CR35], [@CR36]\]. Host and control library reads were filtered using the Filter sequences by mapping v0.0.4 tool in Galaxy \[[@CR37]\]. The forward and reverse files, which were no longer synchronized due to adapter trimming and filtering, were re-synchronized using in-house tool. Overlapping read pairs were joined with PEAR v0.9.6.0 \[[@CR38]\]. Chimeric Nextera reads were removed by an in-house tool which discarded single reads with partial mappings in opposite orientations. Digital normalization via median k-mer abundance was performed using the Khmer package v1.1-1 (cutoff = 100, kmer size = 20, number of tables to use = 4, table size = 1e9) \[[@CR39], [@CR40]\]. *De novo* assembly was performed using the MIRA assembler v3.4.1 \[[@CR41]\]. The following parameters and settings were specified for the assembly step: assembly method = *de* novo, assembly quality grade = accurate, use read extension = yes, minimum reads per contig = 100, minimum overlap = 16, mark repeats = yes, maximum megahub ratio = 0.2, spoiler detection = yes, with default settings for the rest of the parameters. Reference-based orientation and scaffolding of the contigs produced by the assembler were performed using V-FAT v1.0.0 (Broad Institute, Cambridge, MA, USA). The consensus sequence was then re-called based on BWA-MEM mapping of trimmed but un-normalized read data to the genome scaffold and parsing of the mpileup alignment using in-house software. As a final step, LoFreq \[[@CR42]\] was used to estimate variant frequencies in the obtained genomic data. A graphic representation of all major steps included in the sample preparation and analyses is provided in Additional file [2](#MOESM2){ref-type="media"}: Figure S1. The obtained sequences were phylogenetically analyzed with closely related sequences of isolates deposited in GenBank using MEGA6 \[[@CR43]\], as previously described \[[@CR25]\].Fig. 1Customized Galaxy workflow used in the current study. *Double arrows* indicate steps where the read pairs were processed in parallel. *Blue shading* indicates pre-processing steps; *green shading* indicates assembly/post-processing steps; output is shaded purple. "In" indicates input filetypes; "out" indicates output filetypes

Results {#Sec10}
=======

Nucleic acids quantification and libraries fragment size {#Sec11}
--------------------------------------------------------

The nucleic acid concentrations obtained at different steps throughout the preparation of the libraries for sequencing are summarized in Additional file [3](#MOESM3){ref-type="media"}: Table S2. The lowest detected RNA concentration was 2 ng/μl and the maximum was 55 ng/μl. After RNA purification, the RNA concentrations of five samples were below the detection limit of Qubit (250 pg/μl); however, these samples resulted in sufficient cDNA quantity to be further processed in library preparation. The generated libraries had a relatively narrow combined distribution of mean fragment lengths (mean 351 bp, standard deviation 30 bp, with 26 of 30 libraries within the range of 334 to 371 bp) (see Additional file [3](#MOESM3){ref-type="media"}: Table S2). It was observed that the true fragment length distributions observed post-sequencing were shorter than expected based on Bioanalyzer reports, even after counting for adapter length (Table S2). As a result, a large proportion (more than 90% in nearly all libraries) of read pairs overlapped at the ends. The source of the discrepancy with the Bioanalyzer estimates is still unclear.

Summarized statistics of the sequencing run {#Sec12}
-------------------------------------------

A summary of the sequencing run statistics as estimated by the MiSeq instrument is provided in Table [1](#Tab1){ref-type="table"}. A cluster density of 917 +/- 19 K/mm^2^ and 92.34% of the clusters passing the chastity filter yielded a total of 8.4 Gigabases of data. Of 17.7 million total reads, 96.31% passed the instrument quality control filter. Almost 80% of the bases were assigned Phred quality scores equal or greater to Q30 (Q30 score is equivalent to an expected error rate of 0.001). The fraction of reads in the pool assigned to each sample varied from 0.0007 to 7.16% (mean 3.2 ± 1.4%).Table 1Statistics of next-generation sequencing of 30 avian paramyxovirus isolates in a single runDataResultsCluster density (K/mm^2^)^a^917 +/- 19Clusters passing filter^b^92.34%Total number of reads17762176Pass-filter reads^c^16403251Percentage of reads passing filter96.31%≥ Q30^d^77.9%Lowest representation for any index^e^0.0007%Highest representation for any index^e^7.16%^a^ shows number of clusters per square millimeter (optimal cluster density is 1000--1200, can vary with chemistry)^b^ indicates the purity of the signals detected from the clusters (i.e. signals passing chastity filter that is the ratio of the brightest base intensity divided by the sum of the brightest and second brightest base intensities and the filtration process removes the least reliable clusters from the image analysis results)^c^ reads passing filter (about 15 million reads are expected from an optimally clustered flow cell)^d^ percentage of bases with Phred quality score equal or greater to 30^e^ percentage of pass-filter reads assigned to any index

Optimization of the assembly/analysis workflow {#Sec13}
----------------------------------------------

In order to take advantage of the overlapping reads, a merging step was introduced to produce longer pseudo-reads and to reduce complexity of the assembly task. An essential optimization was made by reducing the estimated coverage depth to a level that would still produce optimal assemblies. Two techniques for data reduction were investigated. Random sub-sampling resulted in loss of specific regions in the genome with reproducibly low coverage (data not shown). Digital normalization, which aims to down-sample high-coverage regions while preserving reads from low-coverage areas, provided means for decreasing the number of used reads to an optimal level without loss of data, and thus, was incorporated into the customized Galaxy workflow prior to assembly. In order to determine an optimal target depth for assembly, preliminary test assemblies using the Velvet assembler v1.2.10 \[[@CR44]\] were performed on a geometric progression of sampling depths from 10x to 10000x (the approximate depth of the raw data) with an additional optimization of the velvetg "cov_cutoff" parameter for each depth (parameter used to low coverage nodes). The results indicated that optimal (in this case, full-length) assembly occurred over a range of approximately one order of magnitude (100x to 1000x). Below and above this range, fragmentation began to occur (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Analysis of Newcastle disease virus genome assembly at various read depths. Shown are the longest contig produced at each read depth as a fraction of the full genome length. Subsamples up to 200x were generated using digital normalization. Above 200x, additional reads were added using random subsampling (due to issues with high median cutoffs in the kh-mer package). At each subsampling depth, the final velvetg assembly was optimized for maximum contig length based on the "cov_cutoff" parameter

Data analysis {#Sec14}
-------------

The final outputs of the analysis workflow for each sample included a consensus genome scaffold (.fasta), a file of all assembled contigs (.fasta), a variant frequency call file (variant call format or .vcf) and a set of summary statistics on the run and the assembly. An in-depth summary of the outputs from all samples is presented in Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}, including detailed information on read quality and depth distributions and genome coverage per sample. A total of 29 full-length or near-full-length APMV genomes (99.56% mean genome coverage) were obtained from 30 libraries with only one sample (\#1005) having coverage below 99% and nine samples having 100% coverage (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}). The lower and upper quartiles of median depth per position of the sequencing results were 2984 and 6894 respectively, allowing for accurate detection of low-frequency single nucleotide variants. In fact, all but one NDV samples had a median read depth of at least 2583 (the exception, sample 1005, was found to consist of approximately 98% avian influenza virus reads after host filtering). In addition to NDV genome assembly, the *de novo* strategy allowed for the detection of full-length and near-full-length genomes of avian influenza virus (AIV) in libraries of isolates 998, 1005, 1009 and 1011 \[[@CR45]\], as well as infectious bronchitis virus (IBV) in samples 1003 and 1009. The coverage of the two obtained IBV genomes was 85.78 and 99.37%, while the sequenced AIV genes had coverages ranging between 92.23 and 100%, and two complete AIV genomes were sequenced (see Table [3](#Tab3){ref-type="table"}). The estimated median depths for the IBV (5 and 22) and AIV (from 35 to 1274) isolates were lower (Table [3](#Tab3){ref-type="table"}), most likely reflecting the lower titer of these viruses in the samples. Sample 959 was identified as a member of the novel APMV serotype 13 and the median depth for this sample was 3484. The host reads were between 0.1 and 5.4% (average 1.3%) of all reads per sample. No data was obtained from the library of sample 688 (only 0.0007% of the raw reads were assigned to this sample). The results from the comparison of the three NDV libraries prepared side-by-side with and without the capture step showed identical accuracy, not significantly affected overall coverage and near full-length and full-length genomes were obtained using both approaches. However, the number of NDV-specific reads decreased by approximately 30% when the capture step was not performed (see Table [4](#Tab4){ref-type="table"}).Table 2Summary of sequencing and assembly data of 25 avian paramyxovirus isolatesIsolate number% PF reads^a^Number of raw read pairsNumber of filtered read pairs^b^Forward read quality^c^Reverse read quality^c^Identified virusFinal coverage depth^c^Number of reads used for consensus^d^Consensus nucleotide lengthMissing positions at 5\' end^e^Length of internal gapsMissing positions at 3\' end^e^Percent coverage^e^10022.494091934051372\|37\|38\|38\|382\|36\|37\|38\|38NDV0\|3680\|6088\|7868\|18004390740151246899.5510042.674377554323612\|37\|38\|38\|382\|34\|37\|38\|38NDV0\|4185\|6151\|7909\|14329422150151256799.5610074.206885246816912\|37\|38\|38\|382\|36\|37\|38\|38NDV0\|817\|3648\|7368\|19348665220151256799.569941.392275002261962\|37\|38\|38\|382\|36\|37\|38\|38NDV0\|1758\|2756\|4186\|14276219609151217199.539951.382260502244162\|36\|37\|38\|382\|34\|36\|37\|38NDV0\|2162\|2995\|4197\|9101216240151108299.469961.532512382503382\|37\|38\|38\|382\|34\|37\|37\|38NDV0\|2383\|3175\|4411\|916724215815104206899.4210013.796216556180022\|37\|38\|38\|382\|36\|37\|38\|38NDV0\|4653\|6784\|9510\|21623594361151227099.549971.722813762662512\|37\|38\|38\|382\|35\|37\|38\|38NDV0\|1937\|3026\|4030\|964523377515104226699.429991.702792072721052\|37\|38\|38\|382\|36\|37\|38\|38NDV0\|1728\|2583\|4496\|11915241105151088499.4510001.742850792805962\|37\|38\|38\|382\|35\|37\|38\|38NDV0\|2338\|3107\|4441\|8796241724151177599.519593.605904945882122\|37\|38\|38\|382\|37\|38\|38\|38APMV-131\|2250\|3484\|5801\|23998531520161262099.889604.347119097093772\|37\|37\|38\|382\|37\|37\|38\|38NDV0\|3738\|5631\|7347\|1949162883715135253299.629614.617561977534872\|36\|37\|38\|382\|35\|37\|38\|38NDV0\|4585\|6509\|8206\|14939674667151672599.849623.355488335476222\|37\|38\|38\|382\|35\|37\|38\|38NDV2\|4617\|6340\|8772\|1471952955315192100.009673.716078765979022\|37\|38\|38\|382\|36\|37\|38\|38NDV2\|2673\|3928\|6881\|2607256265715192100.009684.467316927278382\|37\|38\|38\|382\|35\|37\|38\|38NDV0\|2507\|4136\|7393\|22877636218151671999.876957.16115651611294152\|36\|37\|38\|382\|35\|37\|38\|38NDV2\|1678\|3827\|6301\|3286295582915192100.007143.986536036432462\|37\|37\|38\|382\|36\|37\|38\|38NDV1\|2082\|3513\|6724\|3505257082515192100.007153.635948025802232\|37\|38\|38\|382\|36\|37\|38\|38NDV10\|2608\|5633\|8881\|2880952688515192100.007204.056637576579822\|37\|37\|38\|382\|35\|37\|38\|38NDV13\|3821\|6267\|9252\|2743952531315192100.008613.515760775748642\|37\|38\|38\|382\|35\|37\|38\|38NDV6\|3930\|6419\|8881\|2715355939415192100.008674.116735106687812\|37\|38\|38\|382\|36\|37\|38\|38NDV0\|4284\|6079\|9028\|23441647586151761699.898923.926427536422502\|37\|38\|38\|382\|35\|37\|38\|38NDV1\|5147\|7049\|9922\|18221618591151801299.929134.066656406613502\|36\|37\|38\|382\|35\|37\|38\|38NDV0\|2278\|3784\|7011\|3184256628015192100.006880.01no dataNANANANANANANANANANA*NA* not applicable^a^ the fraction of reads assigned to each sample out of all number of reads that passed filter (i.e. pass-filter reads)^b^ the number of paired reads remaining after host and internal control filtering^c^ numbers represent distribution (minimum \| lower quartile \| median \| upper quartile \| maximum)^d^ numbers of paired reads used to re-call the final consensus for each sequence^e^ the missing nucleotides at the ends and the fraction of the expected full genome length covered by the consensus scaffold (i.e. not containing unknown nucleotides) Table 3Summary of sequencing and assembly data of five samples that were identified to have mixed populations of Newcastle disease virus (NDV) and other avian virusesIsolate number% PF reads^a^Number of raw read pairsNumber of filtered read pairs^b^Forward read quality^c^Reverse read quality^c^Identified virusFinal coverage depth^c^Number of reads used for consensus^d^Consensus nucleotide lengthMissing positions at 5\' end^e^Length of internal gapsMissing positions at 3\' end^e^Percent coverage^f^*10033.335467975405192\|37\|38\|38\|382\|36\|37\|38\|38NDV0\|4229\|6090\|8762\|18055525597151276599.57IBV* ^*g*^*0\|2\|5\|8\|449042371126936441885.7810053.445641011230242\|36\|37\|38\|382\|33\|36\|37\|38NDV* ^*h*^*0\|7\|13\|19\|361161144943432728395.41AIV* ^*i*^ *- PB22\|685\|1003\|1446\|2774168042283100.00AIV - PB12\|1845\|2896\|3432\|4634382612334100.00AIV - PA68\|1180\|1496\|1970\|4721234662151100.00AIV - HA12\|595\|1057\|1598\|2604146871683100.00AIV - NP25\|886\|1306\|1867\|2563112521497100.00AIV - NA11\|416\|838\|1030\|169277071410100.00AIV - M1, M211\|210\|811\|1357\|21955699982100.00AIV - NEP, NS115\|396\|787\|1222\|17073796838100.0010093.215264255198542\|37\|38\|38\|382\|36\|37\|38\|38NDV0\|4216\|6887\|9403\|18079485669151276599.57IBV0\|15\|22\|35\|92374327469136191899.37AIV - PB20\|137\|175\|272\|54527912283100.00AIV - PB13\|370\|651\|835\|1177769223242098.99AIV - PA0\|88\|117\|183\|44616752151100.00AIV - HA0\|113\|256\|342\|57823991683100.00AIV - NP0\|145\|277\|333\|52321171485100.00AIV - NA4\|118\|225\|317\|63722261410100.00AIV - M1,M22\|46\|132\|183\|2467939582496.71AIV - NEP, NS10\|47\|83\|103\|139368838100.0010113.445650835381712\|37\|38\|38\|382\|36\|37\|38\|38NDV1\|3272\|5386\|7121\|1610149937815192100.00AIV - PB20\|181\|290\|462\|125462422283100.00AIV - PB12\|323\|482\|609\|107777282334100.00AIV - PA8\|127\|172\|220\|43727432151100.00AIV - HA3\|217\|449\|685\|90653061683100.00AIV - NP3\|180\|380\|605\|75843141497100.00AIV - NA3\|74\|98\|153\|24213831410100.00AIV - M1,M24\|59\|255\|372\|5792092982100.00AIV - NEP, NS13\|29\|70\|137\|216516808100.009981.802956622942172\|37\|38\|38\|382\|35\|37\|38\|38NDV0\|2248\|3275\|4719\|1152828049215103206999.41AIV - PB20\|22\|33\|48\|7847722463498.51AIV - PB10\|34\|56\|85\|12569822176097.36AIV - PA2\|28\|55\|106\|17876721411099.53AIV - HA0\|9\|18\|29\|5320416434097.65AIV - NP0\|24\|43\|82\|126430145635697.26AIV - NA1\|21\|28\|41\|832721304317592.23AIV - M1,M20\|8\|28\|65\|871969235692.62AIV - NEP, NS10\|9\|17\|28\|4094810100.00*^a^ the fraction of reads assigned to each sample out of all number of reads that passed filter (i.e. pass-filter reads)^b^ the number of paired reads remaining after host and internal control filtering^c^ numbers represent distribution (minimum \| lower quartile \| median \| upper quartile \| maximum)^d^ numbers of paired reads used to re-call the final consensus for each sequence^e^ for avian influenza viruses, the missing nucleotides refer to the beginning and the end of the coding sequences of the genes^f^ the fraction of the expected full genome length covered by the consensus scaffold (i.e. not containing unknown nucleotides), for avian influenza genes, the coverage represents comparison to the coding sequences of the genes only^g^ Infectious bronchitis virus^h^ coverage depth and number of reads used to re-call the final consensus for this NDV isolate were impacted by the presence of influenza virus A in the sample (influenza reads were estimated to be approximately 98% of all reads, data not shown)^i^ Avian influenza virus; PB2 = segment 1 polymerase PB2; PB1 = segment 2 polymerase PB1; PA = segment 3 polymerase PA; HA = segment 4 hemagglutinin; NP = segment 5 nucleocapsid protein; NA = segment 6 neuraminidase; M1, M2 = segment 7 matrix protein 1 and matrix protein 2; NEP = segment 8 nuclear export protein and nonstructural protein 1 Table 4Comparison of differences in number of reads and genome coverage of three samples prepared with and without capture of NDV RNAVirus designationNumber of reads% fewer reads without captureIdentity of consensus sequencesMissing sequences at genome termini and internal gaps (in number of nucleotides)With captureWithout captureWith captureWithout capture5′gaps3′5′gaps3′69140351528350129.7100%2000260069836396226245227.9100%000250090141566128540531.3100%094022840

While the high-throughput workflow sometimes resulted in short segments of missing data at the genome termini and/or at one short internal gap, complete sequences for all coding regions of the 29 APMV positive samples were obtained directly from the workflow. Nearly all of the short missing regions occurred at either the termini (a common issue in viral NGS sequencing) \[[@CR46]\] or at one specific intergenic location in the genome between genes N and P which displayed extremely low coverage in all analyzed samples (possibly as a result of high GC content -- 76%). For the purpose of submitting full-length NDV sequences to GenBank, we sequenced the termini using a previously described protocol \[[@CR47]\] and primers designed for the current study (see Additional file [4](#MOESM4){ref-type="media"}: Table S3). The internal gaps, where necessary, were sequenced using PCR and Sanger sequencing (for primers sequences see Additional file [4](#MOESM4){ref-type="media"}: Table S3). This additional work was not included in the time/cost estimates, as it was performed to submit complete NDV sequences to GenBank and would not be necessary for a full analysis of the coding regions.

Time and cost estimates {#Sec15}
-----------------------

The time and cost estimates for all steps are summarized in Additional file [5](#MOESM5){ref-type="media"}: Table S4. Assuming the addition of the first reagent as the start and the final dilutions of the samples as the end of the procedure, the approximate time taken for preparing 30 samples was 25 to 30 person-hours. The sequencing run (500 cycle kit) lasted 39 h. Submission of the raw data to the customized Galaxy workflow and data analysis on the cluster took an additional 2 to 3 h. The average cost of all steps, including all reagents but excluding labor, depreciation and maintenance of equipment, was estimated to be approximately 106 USD per sample.

Discussion {#Sec16}
==========

Next-generation sequencing has been previously described for whole-genome sequencing of NDV by our team and others \[[@CR48]--[@CR55]\]; however, this study is the first report that demonstrates robust simultaneous genomic characterization of multiple NDV viruses in a single NGS run. The study further demonstrates the added benefit of conducting random non-targeted sequencing with an optimized *de novo* assembly workflow for identification of mixed viral infections. In contrast to previous work, here an optimized and customized workflow that employs publically available tools and produced consistently high quality assemblies of complete genomes is described in details. This study also provides detailed statistical and sequencing information that allows quality and quantity assessment of the obtained results.

Our findings demonstrate that the described chemistry and bioinformatics approach is sufficiently robust to obtain and distinguish the complete genomes of completely different types of RNA viruses during a mixed infection. In addition to the conclusive results with NDV and APMV-13 (family *Paramyxoviridae*), the complete or near complete genomes of four avian influenza and two infectious bronchitis viruses, which were co-infecting five samples originally identified as Newcastle disease viruses alone, were also obtained. Infectious bronchitis viruses belong to the family *Coronaviridae* and are single-stranded positive-sense RNA viruses with genome size of approximately 27,5 to 28 kb, excluding the poly (A) tail, which includes ten open reading frames \[[@CR56]\]. The avian influenza viruses belong to the family *Orthomyxoviridae* and have genomes containing eight segments of single-stranded, negative-sense RNA that code for 10 or 11 proteins, depending on the strain \[[@CR57]\]. Despite the diverse nature of the RNA present in samples with mixed populations, the procedure described here successfully produced complete genomes of these viruses.

Our results also demonstrate the capability of the methodology to produce quality libraries and assemblies without any physical or mechanical enrichment. The cDNA and dsDNA concentrations were not found to be proportional to the initial total RNA concentrations. The introduced nuclease step aided digestion of host nucleic acids resulting in low average number (see Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}) of host-associated reads per sample. The abundance of host nucleic acids may pose a problem in obtaining sufficient numbers of viral reads for optimal viral genome assembly \[[@CR4]\]. To avoid or decrease problems caused by contamination with host sequences others have developed methodologies for enrichment of target viral RNAs. We have not utilized any pretreatment or purification; however, a target-specific capture step with biotinylated oligos designed from three different conservative regions of the NDV genome was tested. The comparison of results from samples with and without the RNA capture step presented here demonstrates that the primary tradeoff comes in the form of approximately 30% reduced depth of coverage, although the coverage was still sufficient for proper consensus re-calling (see Table [4](#Tab4){ref-type="table"}). The ability of the capture step to reduce host sequences and other non-target RNA and to improve downstream assembly and analysis should be further assessed on different sample types (e.g. clinical samples, formalin-fixed paraffin-embedded samples) that may contain less amounts of viral RNA. For egg-grown viruses with high viral titers the observed decrease of reads without the RNA capture step was not essential for obtaining complete coverage with sufficient depth. In clinical diagnostic samples, however, the number of NDV sequencing reads is often significantly lower, and introducing the RNA capture step could improve the final results.

There is a clear difference between the presented application of NGS and the use of this approach in diagnostics. Here we describe the use of high-titer egg-grown viruses for production of high quality and deep data useful for detailed genomic characterization and rare variant analyses. However, the use of this NGS technology for diagnostics is more complex. It requires to clearly establish sensitivity, specificity and limit of detection based on the nature of samples and these are beyond the scope of the current work. The described methodology has been successfully transferred for use with clinical samples and optimization studies are in progress in our lab.

Prior to the production run, considerable time was spent optimizing the assembly and analysis workflow for the task at hand. While some of the steps in the workflow are fairly standard procedures in NGS analyses (QC summarization, adapter trimming, contaminant read filtering), others were tailored to the specific characteristics of the data being generated. The most critical optimization, however, was reducing estimated coverage depth to a level that would produce optimal assemblies. It has previously been shown that, past a certain level, increasing read depth can decrease *de novo* assembly quality \[[@CR58]\]. This effect can have significant consequences when working with massively deep sequencing data such as viral population studies that can easily exceed 10000x sample coverage. Digital normalization has been included in similar workflows by others \[[@CR59], [@CR60]\] but is often overlooked in naïve approaches to high-coverage *de novo* assembly. As the assembler used in our workflow (MIRA) is relatively resource-intensive overlap-layout-consensus (OLC) assembler, we chose a target (100x) at the lower end of the empirically determined optimal range to incorporate as a cut-off into the customized production workflow. Graph-based assemblers such as Velvet utilize de Bruijn graph algorithms and assemble data by representing the genome by a set of short k-mer sequences \[[@CR44]\]. Notably, graph-based assemblers are less resource-demanding and can be successfully utilized with limited computational resources. However, for graph-based assemblers, the k-mer size is an essential parameter \[[@CR44], [@CR59], [@CR60]\] and the optimal value has to be determined depending on the characteristics of the sequence reads, while this is avoided using an OLC assembler. In our hands, MIRA consistently produces quality assemblies with minimal tuning needed. Additionally, due to the potential skewing effects of digital normalization and V-FAT scaffolding on the proportion of nucleotide variant frequencies, the post-assembly step to re-map the un-normalized data to the genome scaffold allowed for proper consensus re-calling and precise variant analysis.

One important aspect to the use of NGS approaches in mainstream viral sequencing studies is the capacity to multiplex samples in order to reduce costs. The time and cost summary for all steps (summarized in Additional file [5](#MOESM5){ref-type="media"}: Table S4) demonstrate that the simultaneous processing of 30 samples requires approximate one hour of operator time per sample with a cost of approximately 106 USD per sample. Those values, although still high for diagnostics purposes, are 15 to 20 times lower (based on internal estimates) compared to the cost of primer-based sequencing with Sanger technologies. Furthermore, the demonstrated lower and upper quartiles of median depth per position (2984 and 6894, respectively), allow for accurate consensus re-calling and rare variant analysis. The final output not only includes the consensus genome sequence but also produced a variant call format file (<https://samtools.github.io/hts-specs/VCFv4.2.pdf>) and demonstrate that the protocol could be used for research on viral quasispecies and evolutionary studies (Dimitrov et al., in preparation). As previously reported by Gould et al., the 1998 Newcastle disease outbreak in Australia was preceded by several months of circulation of mutant quasispecies of the virulent cleavage site \[[@CR61]\]. These viral variants were undetected in the Sanger consensus sequences but could have been detected and properly quantified if the methodology described here was available at that time. The obtained genomic coverages (see Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}) illustrate the ability of the described protocol in generating full-length or near-full-length RNA virus genomes. Although very short internal gaps were present due to complete absence of coverage in the raw data and short sequences at the genome termini were missing, all coding sequences (commonly used in genetic studies) were obtained.

The total turnaround time for the entire testing (sample preparation, sequencing and analyses) was approximately 72 h, of which most of the time consisted of library preparation and the sequence run. The duration of the sequencing run could be reduced by approximately 15 h by using a 300-cycle configuration without any anticipated drop-off in assembly quality based on our observed fragment length distributions, although this assumption is untested. The time taken for data analysis may be expected to vary somewhat based on the available computational resources in a lab, although in our protocol this represents a small fraction of the total turnaround time to begin with.

The obtained results were phylogenetically consistent with preliminary studies of the tested viruses (data not shown) and expectations based on previous research. Almost all of the samples from Pakistan were of sub-genotype VIIi which is currently circulating in Pakistan and may be causing a new panzootic \[[@CR25], [@CR62]\]. Ukrainian samples were of different sub-genotypes (II, VIg and VIId) that have been reported to be isolated from pigeons in Ukraine \[[@CR25]\] and also in Europe \[[@CR63]\]. The Nigerian samples were of genotypes XIVb and XVIIa which have been reported to circulate in Nigeria since 2006 \[[@CR64]\] and previously un-sequenced full-length genomes of these sub-genotypes have been reported by us \[[@CR48], [@CR49]\]. In addition, and demonstrating the broad applicability and the advantages of the *de novo* approach described here, the first complete APMV-13 genome was obtained \[[@CR17]\] and avian influenza and infectious bronchitis viruses populations were identified. Phylogenetic analyses of the obtained NDV and IBV sequences are presented in Additional file [6](#MOESM6){ref-type="media"}: Figures S2 and S3).

Conclusion {#Sec17}
==========

In summary, a robust chemistry and bioinformatics protocol utilizing publicly available tools to sequence and analyze complete genomes from small RNA viruses is described. Thirty-five full-length or near-full-length avian RNA viral genomes with a high median coverage depth were successfully sequenced out of 30 samples. The applied *de novo* approach allowed identification of mixed viral populations in some of the samples. The combination of multiplexing NGS technology with the customized Galaxy workflow platform enabled a quick turnaround time and cost-efficient methodology for simultaneous characterization of multiple viral genomes.
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